Neoplastic transformation of mouse mammary epithelial cells by in vitro exposure to N-methyl-N-nitrosourea.
Proc Natl Acad Sci U S A.
1988 Jan;85(2):477-81. doi: 10.1073/pnas.85.2.477. PubMed PMID:
3422439; PubMed Central PMCID:
PMC279573.
Transforming c-Ki-ras mutation is a preneoplastic event in mouse mammary carcinogenesis induced in vitro by N-methyl-N-nitrosourea.
Mol Cell Biol.
1990 Apr;10(4):1593-9. doi: 10.1128/mcb.10.4.1593-1599.1990. PubMed PMID:
2181280; PubMed Central PMCID:
PMC362264.
Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia.
Cancer Res.
1990 Sep 15;50(18):6010-4. PubMed PMID:
2203525.
Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice.
Cancer Res.
1992 Oct 15;52(20):5732-7. PubMed PMID:
1394197.
Autoregulation of I kappa B alpha activity.
Proc Natl Acad Sci U S A.
1994 Jan 4;91(1):28-32. doi: 10.1073/pnas.91.1.28. PubMed PMID:
8278379; PubMed Central PMCID:
PMC42879.
Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.
Mol Cell Biol.
1994 May;14(5):3276-82. doi: 10.1128/mcb.14.5.3276-3282.1994. PubMed PMID:
8164680; PubMed Central PMCID:
PMC358694.
Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation.
Proc Natl Acad Sci U S A.
1994 May 24;91(11):5056-60. doi: 10.1073/pnas.91.11.5056. PubMed PMID:
8197184; PubMed Central PMCID:
PMC43930.
Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation.
Carcinogenesis.
1994 Jul;15(7):1341-6. doi: 10.1093/carcin/15.7.1341. PubMed PMID:
8033309.
Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis.
Proc Natl Acad Sci U S A.
1994 Oct 11;91(21):9789-93. doi: 10.1073/pnas.91.21.9789. PubMed PMID:
7937892; PubMed Central PMCID:
PMC44902.
Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.
Proc Natl Acad Sci U S A.
1994 Dec 20;91(26):12740-4. doi: 10.1073/pnas.91.26.12740. PubMed PMID:
7809113; PubMed Central PMCID:
PMC45515.
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Genes Dev.
1995 Nov 15;9(22):2723-35. doi: 10.1101/gad.9.22.2723. Review. PubMed PMID:
7590248.
Ultraviolet cross-linking of DNA binding proteins.
Methods Enzymol.
1995;254:632-41. doi: 10.1016/0076-6879(95)54045-8. PubMed PMID:
8531720.
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
Mol Cell Biol.
1998 Jan;18(1):19-29. doi: 10.1128/MCB.18.1.19. PubMed PMID:
9418849; PubMed Central PMCID:
PMC121444.
Induction of AP-1 activity by perillyl alcohol in breast cancer cells.
Carcinogenesis.
1999 Oct;20(10):1957-61. doi: 10.1093/carcin/20.10.1957. PubMed PMID:
10506111.
The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain.
J Biol Chem.
1999 Oct 22;274(43):30874-81. doi: 10.1074/jbc.274.43.30874. PubMed PMID:
10521480.
Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites.
J Biol Chem.
1999 Dec 3;274(49):34657-62. doi: 10.1074/jbc.274.49.34657. PubMed PMID:
10574930.
Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation.
FASEB J.
2000 Feb;14(2):379-90. doi: 10.1096/fasebj.14.2.379. PubMed PMID:
10657994.
A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.
Proc Natl Acad Sci U S A.
2000 Feb 1;97(3):1014-9. doi: 10.1073/pnas.97.3.1014. PubMed PMID:
10655476; PubMed Central PMCID:
PMC15505.
NF-kappaB is essential for induction of pro-inflammatory cytokine genes by filarial parasitic sheath proteins.
Mol Immunol.
2000 Feb-Mar;37(3-4):115-23. doi: 10.1016/s0161-5890(00)00039-0. PubMed PMID:
10865110.
NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.
J Biol Chem.
2000 Mar 31;275(13):9501-9. doi: 10.1074/jbc.275.13.9501. PubMed PMID:
10734098.
A switch in distinct I kappa B alpha degradation mechanisms mediates constitutive NF-kappa B activation in mature B cells.
J Immunol.
2000 May 1;164(9):4762-7. doi: 10.4049/jimmunol.164.9.4762. PubMed PMID:
10779782.
Epithelial cells release proinflammatory cytokines and undergo c-Myc-induced apoptosis on exposure to filarial parasitic sheath protein-Bcl2 mediates rescue by activating c-H-Ras.
In Vitro Cell Dev Biol Anim.
2000 Sep;36(8):532-8. doi: 10.1290/1071-2690(2000)036<0532:ECRPCA>2.0.CO;2. PubMed PMID:
11149753.
Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.
Proc Natl Acad Sci U S A.
2000 Oct 24;97(22):11893-8. doi: 10.1073/pnas.220413297. PubMed PMID:
11027313; PubMed Central PMCID:
PMC17265.
Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy.
Ann N Y Acad Sci.
2000;922:274-92. doi: 10.1111/j.1749-6632.2000.tb07045.x. PubMed PMID:
11193903.
Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha.
Mol Cell Biol.
2001 Jul;21(14):4737-47. doi: 10.1128/MCB.21.14.4737-4747.2001. PubMed PMID:
11416149; PubMed Central PMCID:
PMC87155.
Evidence for unique calmodulin-dependent nuclear factor-kappaB regulation in WEHI-231 B cells.
Mol Pharmacol.
2002 Jan;61(1):177-85. doi: 10.1124/mol.61.1.177. PubMed PMID:
11752219.
The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors.
Mol Cell Biol.
2002 Aug;22(16):5813-25. doi: 10.1128/MCB.22.16.5813-5825.2002. PubMed PMID:
12138192; PubMed Central PMCID:
PMC133970.
CD14-dependent activation of NF-kappaB by filarial parasitic sheath proteins.
Cell Biol Int.
2002;26(1):43-54. doi: 10.1006/cbir.2001.0828. PubMed PMID:
11779220.
Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation.
Oncogene.
2003 Sep 1;22(37):5813-27. doi: 10.1038/sj.onc.1206680. Review. PubMed PMID:
12947388.
Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.
Cell.
2003 Nov 26;115(5):565-76. doi: 10.1016/s0092-8674(03)00895-x. PubMed PMID:
14651848.
RelA life and death decisions.
Mol Cell.
2004 Mar 26;13(6):763-4. doi: 10.1016/s1097-2765(04)00158-3. PubMed PMID:
15053867.
A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Biochem J.
2004 May 15;380(Pt 1):173-80. doi: 10.1042/BJ20031796. PubMed PMID:
14763901; PubMed Central PMCID:
PMC1224141.
Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.
Mol Cell Biol.
2004 Jun;24(11):4895-908. doi: 10.1128/MCB.24.11.4895-4908.2004. PubMed PMID:
15143182; PubMed Central PMCID:
PMC416427.
Expanded nuclear roles for IkappaBs.
Sci STKE.
2004 Oct 12;2004(254):pe48. doi: 10.1126/stke.2542004pe48. Review. PubMed PMID:
15479861.
Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival.
Mol Cancer Res.
2005 Jan;3(1):42-9. PubMed PMID:
15671248.
Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells.
Exp Cell Res.
2005 Jul 1;307(1):15-25. doi: 10.1016/j.yexcr.2005.02.015. Epub 2005 Mar 29. PubMed PMID:
15922723.
Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction.
Mol Cancer Res.
2005 Jun;3(6):345-53. doi: 10.1158/1541-7786.MCR-05-0028. PubMed PMID:
15972853.
Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway.
Cancer Res.
2005 Sep 15;65(18):8558-66. doi: 10.1158/0008-5472.CAN-04-4072. PubMed PMID:
16166337.
PIDD: a switch hitter.
Cell.
2005 Dec 16;123(6):980-2. doi: 10.1016/j.cell.2005.11.025. PubMed PMID:
16360026.
Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
Mol Cancer Res.
2006 Feb;4(2):101-12. doi: 10.1158/1541-7786.MCR-05-0259. PubMed PMID:
16513841.
Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.
Science.
2006 Feb 24;311(5764):1141-6. doi: 10.1126/science.1121513. PubMed PMID:
16497931.
NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.
Cancer Res.
2006 Jun 15;66(12):6008-13. doi: 10.1158/0008-5472.CAN-06-0194. PubMed PMID:
16778171; NIHMSID:NIHMS375227.
NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.
Oncogene.
2007 Feb 1;26(5):641-51. doi: 10.1038/sj.onc.1209815. Epub 2006 Jul 24. PubMed PMID:
16862178.
PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
Nat Cell Biol.
2006 Sep;8(9):986-93. doi: 10.1038/ncb1458. Epub 2006 Aug 13. PubMed PMID:
16906147.
Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.
Mol Cell Biol.
2007 Jan;27(2):497-509. doi: 10.1128/MCB.01772-06. Epub 2006 Oct 30. PubMed PMID:
17074802; PubMed Central PMCID:
PMC1800799.
Many faces of NF-kappaB signaling induced by genotoxic stress.
J Mol Med (Berl).
2007 Nov;85(11):1187-202. doi: 10.1007/s00109-007-0227-9. Epub 2007 Jul 3. Review. PubMed PMID:
17607554.
SUMO and NF-kappaB ties.
Cell Mol Life Sci.
2007 Aug;64(15):1979-96. doi: 10.1007/s00018-007-7005-2. Review. PubMed PMID:
17530464; PubMed Central PMCID:
PMC11136396.
CYLD: a DUB with many talents.
Dev Cell.
2007 Nov;13(5):601-603. doi: 10.1016/j.devcel.2007.10.009. PubMed PMID:
17981127.
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma.
Mol Cancer.
2008 May 19;7:40. doi: 10.1186/1476-4598-7-40. PubMed PMID:
18489772; PubMed Central PMCID:
PMC2408930.
What would you like to do?